SlideShare a Scribd company logo
4/23/2016 1
Dr. Md. Eiktier Dewan
Roll No. 0213/10
Registration No. 174
Session: 2013-2014
SUPERVISOR NAME
Prof. Dr. Abdul Ahad
Head, Dept. of Microbiology
and Public Health, CVASU
PRESENTED BY
4/23/2016 2
THESIS TITLE
Transfer Rate of Maternal Antibody (MaAb) Against
Newcastle Disease Virus from Parents to Day Old Chicks.
4/23/2016 3
Contents
 Introduction
 Objectives
 Materials and Methodology
 Results & Discussion
 Conclusion & Recommendation
Acknowledgements
4/23/2016 4
New Castle Disease (ND) also known as Ranikhet
Disease (RD)
Highly contagious viral disease
Attacks many species of domestic and wild birds.
Caused by New Castle Disease Virus (NDV)
 Is a –ve sense ssRNA virus
Family Paramyxoviridae.
Introduction
4/23/2016 5
 ND is a major problem of the large and small scale
poultry industries in Bangladesh
 Vaccination has been reported as the only
safeguard against endemic ND
 Level of MaAb transfer and its half life time is
important for designing a suitable vaccination
program
Cont…
4/23/2016 6
 To estimate the transfer rate of anti-NDV Abs from dams to
their offspring in the Breeder Farm
 To estimate the transfer rate of anti-NDV Abs from dams to
their offspring in the Layer Farm
 Detecting the persistence of MDA in progeny from
vaccinated parent stock
 To provide a guideline in vaccination schedule
Objectives
4/23/2016 7
Materials & Methodology
Study Area
 Study was undertaken within Jan. 2014 to Dec. 2014.
 Three renowned Breeder Farms (BF) and 3 Layer Farms (LF) were
selected randomly from Chittagong
4/23/2016 8
 10 parent’s serum, 10 eggs & 10 DOCs serum samples from
each BF out of total 3 BF
 In each breeder farm samples were taken from 3 age group
i.e. 34, 38 & 42wks
 Similarly 10 parent’s serum, 10 eggs samples were taken
from each LF out of total 3 LF
 From each LF sample were taken from 3 age group i.e. 34,
38 & 42wks
Cont…
4/23/2016 9
Cont…
Sampling layout for BF
Age group(wks) Parents serum DOC’S Serum Egg yolk
34 10 10 10
38 10 10 10
42 10 10 10
Sampling layout for LF
Age group(wks) Parents serum Egg yolk
34 10 10
38 10 10
42 10 10
4/23/2016 10
Blood and eggs from each BF & each LF were collected
randomly by single visit and stored at -200c after serum
collection
 After 21 days from 1st visit, the DOCs were collected from
the hatchery of respective BF
 Day old chicks (DOCs) were sacrificed and Serum was
then separated and stored at -20oC until analyzed
All the tests were done in the CVASU microbiology and
the PRTC laboratory
Cont…
4/23/2016 11
The assay(ELISA)was performed according to the
protocol and suppliance provided by the Biochek
commercial ELISA kit.
Cont…
B. Separation of serum from bloodA. Collected sera samples
4/23/2016 12
Data was stored in a Excel sheet.
The immune status of the birds and comparison was
done using analysis of variance (ANOVA).
A confidence level of 95% was as a cut off to show
the level of significance.
Cont…
4/23/2016 13
Age in
wks
Parent DOC Egg yolk
Mean ±
SD
P value Mean ±
SD
P value Mean ±
SD
P
value
34 10933.6±
2300.75
.774 9805.9±
4843.35
.096 14081±21
90.43
.336
38 10211.1±
2190.60
5784.4±
3110.09
12537.9±
2965.51
42 10586.2±
2245.35
9055.2±
4535.7
13671±18
07.13
Antibody titre against ND in Breeder Farm (BF1)
Results & Discussion
4/23/2016 14
Antibody transfer percentage (%) in BF1.
128.79
122.79
129.14
89.66
56.65
85.54
0
20
40
60
80
100
120
140
34 wks 38 wks 42 wks
yolk%
DOC%
Cont…
AGE(WKS) Type
21 Killed
27 Live
33 Live
39 Live
45 Live
Maintained ND vaccination
schedule
4/23/2016 15
Age in wks Parent DOC Egg
Mean ± SD P value Mean ± SD P value Mean ±
SD
P
value
34 15381.6±36
33.67
.006 10814.4±1
919.86
.316 12394±1
591.76
.005
38 18274.2±21
00.72
12299.3±1
828.7
14993.5±
2628.18
42 13240.3±36
68.77
11726.4±2
639.38
10967.5±
1636.34
Antibody titre against ND in Breeder Farm (BF2)
Cont…
4/23/2016 16
80.58 82.05 82.83
70.3 67.3
88.57
0
20
40
60
80
100
34 wks 38 wks 42 wks
yolk %
DOC %
Antibody transfer percentage (%) in BF2.
Cont…
AGE(WKS) Type
20 Killed
27 Live
34 Live
41 Live
48 Live
Maintained ND vaccination schedule
4/23/2016 17
Age in
wks
Parent DOC Egg
Mean ±
SD
P value Mean ±
SD
P value Mean ±
SD
P
value
34 12971.5±
1957.66
.180 9280±326
2.97
.198 11627.1±
4357.31
.849
38 11345.8±
1352.27
9265.8±1
786.33
9779.4±3
860.25
42 10820.7±
3875.56
8648.7±2
357.07
8714.7±2
257.94
Antibody titre against ND in Breeder Farm (BF3)
Cont…
4/23/2016 18
Antibody transfer percentage (%) in BF3.
89.64 86.19 80.54
71.54
81.67 79.93
0
20
40
60
80
100
34 wks 38 wks 42 wks
yolk%
DOC%
Cont…
AGE(WKS) Type
22 Killed
29 Live
36 Live
43 Live
50 Live
Maintained ND vaccination schedule
4/23/2016 19
Age in wks Parent Egg
Mean ± SD P value Mean ± SD P value
34 10229.3±321
7.5112
.383 6749.2±253
1.4799
.052
38 12434.3±364
1.9266
4473±1418.
6051
42 11885.9±401
8.0102
5296.9±190
1.8988
Antibody titre against ND in Layer Farm (LF1)
Cont…
4/23/2016 20
Age in wks Parent Egg
Mean ± SD P value Mean ± SD P
valu
e
34 14710.4±1713.
8471
.0004 7094.4±3418.
4783
.148
38 13526.3±1826.
6526
7082.8±1235.
7472
42 10881.3±2188.
8898
5361.6±1144.
6295
Antibody titre against ND in Layer Farm (LF2)
Cont…
4/23/2016 21
Age in wks Parent Egg
Mean ± SD P value Mean ± SD P
valu
e
34 10395.1±2332.
1158
.717 7949.9±1695.
8026
.017
38 11398.4±1953.
9885
5998.3±2039.
1278
42 10961.1±3643.
2464
5497.6±1883.
2991
Antibody titre against ND in Layer Farm (LF3)
Cont…
4/23/2016 22
Antibody transfer percentage (%) from parent to egg yolk
in Layer Farms.
65.98
35.98
44.56
48.23
52.36 49.27
76.48
52.62 50.16
0
10
20
30
40
50
60
70
80
90
34 WKS38 WKS42 WKS
LF 1
LF 2
LF 3
Cont…
Age Type
16 18 Killed
24 25 24 live
32 32 31 live
40 39 38 live
48 46 45 live
LF1 LF2 LF3
17
Maintained ND vaccination
schedule
4/23/2016 23
Cont…
ELISA test of our study revealed that, the anti-NDV
titre of the mentioned BF and LF were different at
different ages.
4/23/2016 24
 Vaccination protocol in breeder and layer farms mainly
leads this variation.
 Infection load of NDV also plays significant role in this
aspect.
 Thereafter ELISA is a sensitive test not specific leads
a little deviation of expected solid & accurate estimation
and it can detect all functional types of Abs.
ELISA is therefore, proved more practical, sensitive and
rapid for detection of Ab titres against NDV vaccines
compared to the HI test.
The obtained results ,revealed that ELISA can detect high
levels of Abs and considered accurate and sensitive compared
to HI test.
Cont…
4/23/2016 25
The estimated half life time of ND maternal antibody
level is 6.3 days
In G e o r g i a Po u l t r y, 2010 – 2012 the baseline
Broiler Breeder NDV titers at 30-34wks was 3435, at 35-
39wks was 3493 & at 40-44wks was
Conclusion & Recommendation
4/23/2016 26
In BF1 transfer rate of MaAb was 89%, 56% & 85%
respectively after 1wk, 5wks & 3wks of post vaccination
So we concluded our study findings as following:
4/23/2016 27
In BF2 transfer rate of MaAb was 70.3%, 67.3% &
88.57% respectively after 1wk, 4wks & 2wks of post
vaccination
In BF3 transfer rate of MaAb was 71.54%, 81.67% &
79.93% respectively after 5wks, 2wks & 4wks of post
vaccination
DOC from BF1 from 34 & 42wks should be vaccinated
within 10 days whereas DOC from 38wks should be
vaccinated within 7 days
DOC from BF2 from 34 & 42wks should be vaccinated
within 10 days whereas DOC from 38wks should be
vaccinated within 15 days
DOC from BF3 from 34 & 38wks should be vaccinated
within 10 days whereas DOC from 42wks should be
vaccinated within 7 days
According to this study, the maternally derived
antibodies persists up to 5 to 15 days in progeny after
hatching & vaccine must be given within this time
4/23/2016 28
Cont…
I express my gratitude to my supervisor Prof. Dr. Abdul Ahad . I also extend
my thanks to all members of the dept. of Microbiology and Veterinary Public
Health.
•Dr. Nitish Chandra Debnath , Professor, Department of Microbiology and
Veterinary Public Health
•Dr. Paritosh Kumar Biswas , Professor, Department of Microbiology and
Veterinary Public Health
•Dr. Abdul Ahad , Professor, Department of Microbiology and Veterinary
Public Health
•Dr. Himel Barua , Associate Professor, Department of Microbiology and
Veterinary Public Health
•Dr. Abul Kashem , Assistant Professor, Department of Microbiology and
Veterinary Public Health
•Dr. Md. Zohorul Islam, Assistant Professor, Department of Microbiology
and Veterinary Public Health
•Dr. Mukta Das Gupta, Assistant Professor, Department of Microbiology and
Veterinary Public Health
ACKNOWLEDGEMENTS
4/23/2016 29
Thanks to All
4/23/2016 30

More Related Content

What's hot

Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...
Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...
Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...
John Blue
 
Chelonian diagnostics, pathology and treatment
Chelonian diagnostics, pathology and treatmentChelonian diagnostics, pathology and treatment
Chelonian diagnostics, pathology and treatment
mgray11
 
Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...
Alexander Decker
 
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 SymposiumOverview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Eastern Pennsylvania Branch ASM
 
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
ILRI
 
Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...
Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...
Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...
John Blue
 
THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...
THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...
THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...
EuFMD
 
Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...
Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...
Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...
Dr. Md. Ehsanul Haque
 
Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...
Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...
Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...
John Blue
 
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Rafael Monleon
 
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...Merial EMEA
 
Dr. X.J. Meng - Designing PRRSV Vaccines for Heterologous Protection
Dr. X.J. Meng - Designing PRRSV Vaccines for Heterologous ProtectionDr. X.J. Meng - Designing PRRSV Vaccines for Heterologous Protection
Dr. X.J. Meng - Designing PRRSV Vaccines for Heterologous Protection
John Blue
 
Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...
Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...
Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...
Adil Mufti
 
J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50Huma Qureshi
 
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy MeasuresDr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
John Blue
 
Clinical use of serum parvovirus and distemper virus antibody titers for dete...
Clinical use of serum parvovirus and distemper virus antibody titers for dete...Clinical use of serum parvovirus and distemper virus antibody titers for dete...
Clinical use of serum parvovirus and distemper virus antibody titers for dete...
Yotam Copelovitz
 
01 sergio lopez soria
01 sergio lopez soria01 sergio lopez soria
01 sergio lopez soriaMerial EMEA
 
OS16 - 2.P3.d Genetic and Antigenic Variation of FMD Virus During Persisten...
OS16 - 2.P3.d   Genetic and Antigenic Variation of FMD Virus During Persisten...OS16 - 2.P3.d   Genetic and Antigenic Variation of FMD Virus During Persisten...
OS16 - 2.P3.d Genetic and Antigenic Variation of FMD Virus During Persisten...
EuFMD
 
COVID 19 Búsqueda - Dr. Freddy Flores Malpartida
COVID 19 Búsqueda - Dr. Freddy Flores MalpartidaCOVID 19 Búsqueda - Dr. Freddy Flores Malpartida
COVID 19 Búsqueda - Dr. Freddy Flores Malpartida
Freddy Flores Malpartida
 
El medicamento aprobado por la FDA ivermectina
El medicamento aprobado por la FDA ivermectinaEl medicamento aprobado por la FDA ivermectina
El medicamento aprobado por la FDA ivermectina
DanielErnestoEscobar
 

What's hot (20)

Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...
Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...
Dr. PH Rathkjen - Porcine Reproductive & Respiratory Syndrome (PRRS) around t...
 
Chelonian diagnostics, pathology and treatment
Chelonian diagnostics, pathology and treatmentChelonian diagnostics, pathology and treatment
Chelonian diagnostics, pathology and treatment
 
Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...
 
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 SymposiumOverview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
 
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
Development of diagnostic tools to reduce antimicrobial (mis)use: Novel ident...
 
Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...
Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...
Dr. Hanchun Yang - Pathogenesis and control of Chinese highly pathogenic Porc...
 
THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...
THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...
THE CHANGES OF SEROLOGICAL CROSS-REACTIVITY BETWEEN HOMOLOGOUS AND HETEROLOGO...
 
Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...
Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...
Sensitivity and Specificity of an In-house Sandwich ELISA Kit for Newcastle D...
 
Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...
Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...
Dr. Megan Niederwerder - The role of the microbiome in Porcine Reproductive &...
 
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
 
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
Ipvs2014 02 mortensen et al.-pcv2 circulation control in danish fatteners abs...
 
Dr. X.J. Meng - Designing PRRSV Vaccines for Heterologous Protection
Dr. X.J. Meng - Designing PRRSV Vaccines for Heterologous ProtectionDr. X.J. Meng - Designing PRRSV Vaccines for Heterologous Protection
Dr. X.J. Meng - Designing PRRSV Vaccines for Heterologous Protection
 
Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...
Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...
Venture Diagnostic Test offers Medomices COVID-19 -IgM/ IgG Rapid Anti-Body T...
 
J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50
 
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy MeasuresDr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
Dr. Brian Payne - PCV2: Diagnostics, Control, Protection, and Efficacy Measures
 
Clinical use of serum parvovirus and distemper virus antibody titers for dete...
Clinical use of serum parvovirus and distemper virus antibody titers for dete...Clinical use of serum parvovirus and distemper virus antibody titers for dete...
Clinical use of serum parvovirus and distemper virus antibody titers for dete...
 
01 sergio lopez soria
01 sergio lopez soria01 sergio lopez soria
01 sergio lopez soria
 
OS16 - 2.P3.d Genetic and Antigenic Variation of FMD Virus During Persisten...
OS16 - 2.P3.d   Genetic and Antigenic Variation of FMD Virus During Persisten...OS16 - 2.P3.d   Genetic and Antigenic Variation of FMD Virus During Persisten...
OS16 - 2.P3.d Genetic and Antigenic Variation of FMD Virus During Persisten...
 
COVID 19 Búsqueda - Dr. Freddy Flores Malpartida
COVID 19 Búsqueda - Dr. Freddy Flores MalpartidaCOVID 19 Búsqueda - Dr. Freddy Flores Malpartida
COVID 19 Búsqueda - Dr. Freddy Flores Malpartida
 
El medicamento aprobado por la FDA ivermectina
El medicamento aprobado por la FDA ivermectinaEl medicamento aprobado por la FDA ivermectina
El medicamento aprobado por la FDA ivermectina
 

Viewers also liked

Обучающий вебинар для рекламодателей ВКонтакте
Обучающий вебинар для рекламодателей ВКонтактеОбучающий вебинар для рекламодателей ВКонтакте
Обучающий вебинар для рекламодателей ВКонтакте
Церебро Таргет
 
Winter wear sale 50% off
Winter wear sale 50% offWinter wear sale 50% off
Winter wear sale 50% off
ishitakocher
 
Underlying causes of hair loss
Underlying causes of hair lossUnderlying causes of hair loss
Underlying causes of hair loss
Gajapriya7085
 
Clever Monitor – Global presentation
Clever Monitor – Global presentationClever Monitor – Global presentation
Clever Monitor – Global presentation
Lukas Hakos
 
Lottery a good new year's resolution
Lottery a good new year's resolutionLottery a good new year's resolution
Lottery a good new year's resolution
Gajapriya7085
 
Room2shop pitch desk
Room2shop pitch deskRoom2shop pitch desk
Room2shop pitch desk
Prakash Kaptan
 
Emily_Brazill_CVMay2016
Emily_Brazill_CVMay2016Emily_Brazill_CVMay2016
Emily_Brazill_CVMay2016emily brazill
 
לדעת לנהל בחוכמה
לדעת לנהל בחוכמהלדעת לנהל בחוכמה
לדעת לנהל בחוכמה
Danny Mann
 
Degree and academic transcript
Degree and academic transcriptDegree and academic transcript
Degree and academic transcriptBianca Nortje
 

Viewers also liked (10)

Обучающий вебинар для рекламодателей ВКонтакте
Обучающий вебинар для рекламодателей ВКонтактеОбучающий вебинар для рекламодателей ВКонтакте
Обучающий вебинар для рекламодателей ВКонтакте
 
Winter wear sale 50% off
Winter wear sale 50% offWinter wear sale 50% off
Winter wear sale 50% off
 
Underlying causes of hair loss
Underlying causes of hair lossUnderlying causes of hair loss
Underlying causes of hair loss
 
Clever Monitor – Global presentation
Clever Monitor – Global presentationClever Monitor – Global presentation
Clever Monitor – Global presentation
 
johnson chopamba CV Feb 2017 2
johnson chopamba CV Feb 2017 2johnson chopamba CV Feb 2017 2
johnson chopamba CV Feb 2017 2
 
Lottery a good new year's resolution
Lottery a good new year's resolutionLottery a good new year's resolution
Lottery a good new year's resolution
 
Room2shop pitch desk
Room2shop pitch deskRoom2shop pitch desk
Room2shop pitch desk
 
Emily_Brazill_CVMay2016
Emily_Brazill_CVMay2016Emily_Brazill_CVMay2016
Emily_Brazill_CVMay2016
 
לדעת לנהל בחוכמה
לדעת לנהל בחוכמהלדעת לנהל בחוכמה
לדעת לנהל בחוכמה
 
Degree and academic transcript
Degree and academic transcriptDegree and academic transcript
Degree and academic transcript
 

Similar to thesis final ppt

dkn520.pdf
dkn520.pdfdkn520.pdf
dkn520.pdf
ImeneFl
 
Study of Bacterial isolates with antibiogram from clinically suspected cases ...
Study of Bacterial isolates with antibiogram from clinically suspected cases ...Study of Bacterial isolates with antibiogram from clinically suspected cases ...
Study of Bacterial isolates with antibiogram from clinically suspected cases ...
Saptadeep Roy
 
Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...
Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...
Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...
iosrjce
 
Invicta robertsonian poster eshre 2014
Invicta robertsonian poster eshre 2014Invicta robertsonian poster eshre 2014
Invicta robertsonian poster eshre 2014
INVICTA GENETICS
 
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsAssay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient results
Walt Whitman
 
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
John Blue
 
Wilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paperWilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paperTanya Kapes
 
Human embryo transfer11
Human   embryo   transfer11Human   embryo   transfer11
Human embryo transfer11t7260678
 
複製 Human embryo transfer11
複製  Human   embryo   transfer11複製  Human   embryo   transfer11
複製 Human embryo transfer11t7260678
 
Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...
Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...
Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...
John Blue
 
Gene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virusGene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virusJonathan G. Godwin
 
SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...
SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...
SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...
Henok Abebe
 
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
hivlifeinfo
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
UC San Diego AntiViral Research Center
 
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Meningitis Research Foundation
 
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 

Similar to thesis final ppt (20)

dkn520.pdf
dkn520.pdfdkn520.pdf
dkn520.pdf
 
2007 pcrrflp csp variants
2007 pcrrflp csp variants2007 pcrrflp csp variants
2007 pcrrflp csp variants
 
Study of Bacterial isolates with antibiogram from clinically suspected cases ...
Study of Bacterial isolates with antibiogram from clinically suspected cases ...Study of Bacterial isolates with antibiogram from clinically suspected cases ...
Study of Bacterial isolates with antibiogram from clinically suspected cases ...
 
Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...
Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...
Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycoba...
 
Invicta robertsonian poster eshre 2014
Invicta robertsonian poster eshre 2014Invicta robertsonian poster eshre 2014
Invicta robertsonian poster eshre 2014
 
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsAssay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient results
 
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
 
Publication 3 - 3rd Author
Publication 3 - 3rd AuthorPublication 3 - 3rd Author
Publication 3 - 3rd Author
 
Wilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paperWilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paper
 
Human embryo transfer11
Human   embryo   transfer11Human   embryo   transfer11
Human embryo transfer11
 
複製 Human embryo transfer11
複製  Human   embryo   transfer11複製  Human   embryo   transfer11
複製 Human embryo transfer11
 
Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...
Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...
Dr. Brian Payne - PCV2 Vaccine Cross-Protection: Identification of Sequences ...
 
Gene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virusGene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virus
 
SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...
SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...
SEROPREVALENTSTATUSANDGENETICDIVERSITYOFINFECTIOUSBURSALDISEASEIBDVVIRUSOFPOU...
 
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
 
Acae Nicu Paper Final Subm Correction
Acae Nicu Paper Final Subm CorrectionAcae Nicu Paper Final Subm Correction
Acae Nicu Paper Final Subm Correction
 
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
논문6
논문6논문6
논문6
 

thesis final ppt

  • 2. Dr. Md. Eiktier Dewan Roll No. 0213/10 Registration No. 174 Session: 2013-2014 SUPERVISOR NAME Prof. Dr. Abdul Ahad Head, Dept. of Microbiology and Public Health, CVASU PRESENTED BY 4/23/2016 2
  • 3. THESIS TITLE Transfer Rate of Maternal Antibody (MaAb) Against Newcastle Disease Virus from Parents to Day Old Chicks. 4/23/2016 3
  • 4. Contents  Introduction  Objectives  Materials and Methodology  Results & Discussion  Conclusion & Recommendation Acknowledgements 4/23/2016 4
  • 5. New Castle Disease (ND) also known as Ranikhet Disease (RD) Highly contagious viral disease Attacks many species of domestic and wild birds. Caused by New Castle Disease Virus (NDV)  Is a –ve sense ssRNA virus Family Paramyxoviridae. Introduction 4/23/2016 5
  • 6.  ND is a major problem of the large and small scale poultry industries in Bangladesh  Vaccination has been reported as the only safeguard against endemic ND  Level of MaAb transfer and its half life time is important for designing a suitable vaccination program Cont… 4/23/2016 6
  • 7.  To estimate the transfer rate of anti-NDV Abs from dams to their offspring in the Breeder Farm  To estimate the transfer rate of anti-NDV Abs from dams to their offspring in the Layer Farm  Detecting the persistence of MDA in progeny from vaccinated parent stock  To provide a guideline in vaccination schedule Objectives 4/23/2016 7
  • 8. Materials & Methodology Study Area  Study was undertaken within Jan. 2014 to Dec. 2014.  Three renowned Breeder Farms (BF) and 3 Layer Farms (LF) were selected randomly from Chittagong 4/23/2016 8
  • 9.  10 parent’s serum, 10 eggs & 10 DOCs serum samples from each BF out of total 3 BF  In each breeder farm samples were taken from 3 age group i.e. 34, 38 & 42wks  Similarly 10 parent’s serum, 10 eggs samples were taken from each LF out of total 3 LF  From each LF sample were taken from 3 age group i.e. 34, 38 & 42wks Cont… 4/23/2016 9
  • 10. Cont… Sampling layout for BF Age group(wks) Parents serum DOC’S Serum Egg yolk 34 10 10 10 38 10 10 10 42 10 10 10 Sampling layout for LF Age group(wks) Parents serum Egg yolk 34 10 10 38 10 10 42 10 10 4/23/2016 10
  • 11. Blood and eggs from each BF & each LF were collected randomly by single visit and stored at -200c after serum collection  After 21 days from 1st visit, the DOCs were collected from the hatchery of respective BF  Day old chicks (DOCs) were sacrificed and Serum was then separated and stored at -20oC until analyzed All the tests were done in the CVASU microbiology and the PRTC laboratory Cont… 4/23/2016 11
  • 12. The assay(ELISA)was performed according to the protocol and suppliance provided by the Biochek commercial ELISA kit. Cont… B. Separation of serum from bloodA. Collected sera samples 4/23/2016 12
  • 13. Data was stored in a Excel sheet. The immune status of the birds and comparison was done using analysis of variance (ANOVA). A confidence level of 95% was as a cut off to show the level of significance. Cont… 4/23/2016 13
  • 14. Age in wks Parent DOC Egg yolk Mean ± SD P value Mean ± SD P value Mean ± SD P value 34 10933.6± 2300.75 .774 9805.9± 4843.35 .096 14081±21 90.43 .336 38 10211.1± 2190.60 5784.4± 3110.09 12537.9± 2965.51 42 10586.2± 2245.35 9055.2± 4535.7 13671±18 07.13 Antibody titre against ND in Breeder Farm (BF1) Results & Discussion 4/23/2016 14
  • 15. Antibody transfer percentage (%) in BF1. 128.79 122.79 129.14 89.66 56.65 85.54 0 20 40 60 80 100 120 140 34 wks 38 wks 42 wks yolk% DOC% Cont… AGE(WKS) Type 21 Killed 27 Live 33 Live 39 Live 45 Live Maintained ND vaccination schedule 4/23/2016 15
  • 16. Age in wks Parent DOC Egg Mean ± SD P value Mean ± SD P value Mean ± SD P value 34 15381.6±36 33.67 .006 10814.4±1 919.86 .316 12394±1 591.76 .005 38 18274.2±21 00.72 12299.3±1 828.7 14993.5± 2628.18 42 13240.3±36 68.77 11726.4±2 639.38 10967.5± 1636.34 Antibody titre against ND in Breeder Farm (BF2) Cont… 4/23/2016 16
  • 17. 80.58 82.05 82.83 70.3 67.3 88.57 0 20 40 60 80 100 34 wks 38 wks 42 wks yolk % DOC % Antibody transfer percentage (%) in BF2. Cont… AGE(WKS) Type 20 Killed 27 Live 34 Live 41 Live 48 Live Maintained ND vaccination schedule 4/23/2016 17
  • 18. Age in wks Parent DOC Egg Mean ± SD P value Mean ± SD P value Mean ± SD P value 34 12971.5± 1957.66 .180 9280±326 2.97 .198 11627.1± 4357.31 .849 38 11345.8± 1352.27 9265.8±1 786.33 9779.4±3 860.25 42 10820.7± 3875.56 8648.7±2 357.07 8714.7±2 257.94 Antibody titre against ND in Breeder Farm (BF3) Cont… 4/23/2016 18
  • 19. Antibody transfer percentage (%) in BF3. 89.64 86.19 80.54 71.54 81.67 79.93 0 20 40 60 80 100 34 wks 38 wks 42 wks yolk% DOC% Cont… AGE(WKS) Type 22 Killed 29 Live 36 Live 43 Live 50 Live Maintained ND vaccination schedule 4/23/2016 19
  • 20. Age in wks Parent Egg Mean ± SD P value Mean ± SD P value 34 10229.3±321 7.5112 .383 6749.2±253 1.4799 .052 38 12434.3±364 1.9266 4473±1418. 6051 42 11885.9±401 8.0102 5296.9±190 1.8988 Antibody titre against ND in Layer Farm (LF1) Cont… 4/23/2016 20
  • 21. Age in wks Parent Egg Mean ± SD P value Mean ± SD P valu e 34 14710.4±1713. 8471 .0004 7094.4±3418. 4783 .148 38 13526.3±1826. 6526 7082.8±1235. 7472 42 10881.3±2188. 8898 5361.6±1144. 6295 Antibody titre against ND in Layer Farm (LF2) Cont… 4/23/2016 21
  • 22. Age in wks Parent Egg Mean ± SD P value Mean ± SD P valu e 34 10395.1±2332. 1158 .717 7949.9±1695. 8026 .017 38 11398.4±1953. 9885 5998.3±2039. 1278 42 10961.1±3643. 2464 5497.6±1883. 2991 Antibody titre against ND in Layer Farm (LF3) Cont… 4/23/2016 22
  • 23. Antibody transfer percentage (%) from parent to egg yolk in Layer Farms. 65.98 35.98 44.56 48.23 52.36 49.27 76.48 52.62 50.16 0 10 20 30 40 50 60 70 80 90 34 WKS38 WKS42 WKS LF 1 LF 2 LF 3 Cont… Age Type 16 18 Killed 24 25 24 live 32 32 31 live 40 39 38 live 48 46 45 live LF1 LF2 LF3 17 Maintained ND vaccination schedule 4/23/2016 23
  • 24. Cont… ELISA test of our study revealed that, the anti-NDV titre of the mentioned BF and LF were different at different ages. 4/23/2016 24  Vaccination protocol in breeder and layer farms mainly leads this variation.  Infection load of NDV also plays significant role in this aspect.  Thereafter ELISA is a sensitive test not specific leads a little deviation of expected solid & accurate estimation and it can detect all functional types of Abs.
  • 25. ELISA is therefore, proved more practical, sensitive and rapid for detection of Ab titres against NDV vaccines compared to the HI test. The obtained results ,revealed that ELISA can detect high levels of Abs and considered accurate and sensitive compared to HI test. Cont… 4/23/2016 25
  • 26. The estimated half life time of ND maternal antibody level is 6.3 days In G e o r g i a Po u l t r y, 2010 – 2012 the baseline Broiler Breeder NDV titers at 30-34wks was 3435, at 35- 39wks was 3493 & at 40-44wks was Conclusion & Recommendation 4/23/2016 26 In BF1 transfer rate of MaAb was 89%, 56% & 85% respectively after 1wk, 5wks & 3wks of post vaccination So we concluded our study findings as following:
  • 27. 4/23/2016 27 In BF2 transfer rate of MaAb was 70.3%, 67.3% & 88.57% respectively after 1wk, 4wks & 2wks of post vaccination In BF3 transfer rate of MaAb was 71.54%, 81.67% & 79.93% respectively after 5wks, 2wks & 4wks of post vaccination DOC from BF1 from 34 & 42wks should be vaccinated within 10 days whereas DOC from 38wks should be vaccinated within 7 days
  • 28. DOC from BF2 from 34 & 42wks should be vaccinated within 10 days whereas DOC from 38wks should be vaccinated within 15 days DOC from BF3 from 34 & 38wks should be vaccinated within 10 days whereas DOC from 42wks should be vaccinated within 7 days According to this study, the maternally derived antibodies persists up to 5 to 15 days in progeny after hatching & vaccine must be given within this time 4/23/2016 28 Cont…
  • 29. I express my gratitude to my supervisor Prof. Dr. Abdul Ahad . I also extend my thanks to all members of the dept. of Microbiology and Veterinary Public Health. •Dr. Nitish Chandra Debnath , Professor, Department of Microbiology and Veterinary Public Health •Dr. Paritosh Kumar Biswas , Professor, Department of Microbiology and Veterinary Public Health •Dr. Abdul Ahad , Professor, Department of Microbiology and Veterinary Public Health •Dr. Himel Barua , Associate Professor, Department of Microbiology and Veterinary Public Health •Dr. Abul Kashem , Assistant Professor, Department of Microbiology and Veterinary Public Health •Dr. Md. Zohorul Islam, Assistant Professor, Department of Microbiology and Veterinary Public Health •Dr. Mukta Das Gupta, Assistant Professor, Department of Microbiology and Veterinary Public Health ACKNOWLEDGEMENTS 4/23/2016 29